Recruitment of Th1 effector cells in human tuberculosis: Hierarchy of chemokine receptor(s) and their ligands

Cytokine

Volumn 63, Issue 1, 2013, Pages 43-51

  Saha, Pradip K ^a   Sharma, Prabhat K ^a   Sharma, Surendra K ^a   Singh, Amar ^a   Mitra, Dipendra K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemokines; Miliary tuberculosis; T cells; Tuberculosis

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYCOBACTERIUM ANTIGEN; RANTES;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG LAVAGE; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MALE; MILIARY TUBERCULOSIS; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOSIS;

ADULT; ANTIGENS, CD11A; ANTIGENS, CD3; ANTIGENS, CD45; CELL MOVEMENT; CHEMOKINES; DEMOGRAPHY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; PLEURAL EFFUSION; RECEPTORS, CCR3; RECEPTORS, CCR5; TH1 CELLS; TUBERCULOSIS; TUBERCULOSIS, MILIARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84878936688     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.001     Document Type: Article

References (22)

1. Flynn J.L., Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129.
2. North R.J., Jung Y.J. Immunity to tuberculosis. Annu Rev Immunol 2004, 22:599-623.
3. Mitra D.K., Sharma S.K., Dinda A.K., Bindra M.S., Madan B., Ghosh B. Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment. Eur J Immunol 2005, 35:2367-2375.
4. Sharma S.K., Mohan A., Sharma A., Mitra D.K. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005, 5:415-430.
5. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 2001, 1:20-30.
6. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000, 105:1317-1325.
7. Serbina N.V., Lazarevic V., Flynn J.L. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol 2001, 167:6991-7000.
8. Im J.S., Kang T.J., Lee S.B., et al. Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections. Clin Immunol 2008, 127:214-224.
9. Sharma P.K., Saha P.K., Singh A., Sharma S.K., Ghosh B., Mitra D.K. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med 2009, 179:1061-1070.
10. Qin S., Rottman J.B., Myers P., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998, 101:746-754.
11. Lin P.L., Pawar S., Myers A., et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 2006, 74:3790-3803.
12. Sharma S.K., Mohan A., Pande J.N., Prasad K.L., Gupta A.K., Khilnani G.C. Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. QJM 1995, 88:29-37.
13. Sharma S.K., Mitra D.K., Balamurugan A., Pandey R.M., Mehra N.K. Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 2002, 22:345-352.
14. Mazzone A., Ricevuti G. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica 1995, 80:161-175.
15. Young D.B., Perkins M.D., Duncan K., Barry C.E. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008, 118:1255-1265.
16. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1-8538:893-895.
17. Lu C.Z., Jensen M.A., Arnason B.G. Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol 1993, 46:123-128.
18. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Nat Acad Sci 1999, 96:6873-6878.
19. Panzer U., Reinking R.R., Steinmetz O.M., et al. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 2004, 78:1341-1350.
20. Loetscher P., Uguccioni M., Bordoli L., et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998, 391:344-345.
21. Patel D.D., Zachariah J.P., Whichard L.P. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 2001, 98:39-45.
22. Mitra D.K., Joshi B., Dinda A.K., et al. Induction of lepromin reactivity in cured lepromatous leprosy patients: impaired chemokine response dissociates protective immunity from delayed type hypersensitivity. Microbes Infect 2009, 11:1122-1130.